发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT |
摘要 |
<p>PURPOSE: A pharmaceutical composition is provided to resolve absorption suppression due to drug interaction by formulation of olmesartan medoxomil and rosuvastatin or a salt thereof. CONSTITUTION: A pharmaceutical composition comprises a fraction containing olmesartan medoxomil and a fraction containing rosuvastatin or a salt thereof. The fractions are formed in a single form. The pharmaceutical composition is manufactured in the form of a bilayer tablet, a cored tablet, or a pellet-containing capsule. The pharmaceutical composition is manufactured in a bilayer form comprising a layer containing rosuvastatin or a salt thereof and a layer containing olmesartan medoxomil. The pharmaceutical composition is manufactured in a capsule form comprising a pellet containing rosuvastatin or a salt thereof and a pellet containing olmesartan medoxomil. [Reference numerals] (AA) Olmesartan average concentration in blood (N=12); (BB) Control medicine; (CC) Test medicine</p> |
申请公布号 |
KR20130111335(A) |
申请公布日期 |
2013.10.10 |
申请号 |
KR20130030734 |
申请日期 |
2013.03.22 |
申请人 |
DAEWOONG PHARMACEUTICAL CO., LTD. |
发明人 |
CHANG, HEE CHUL;KANG, BOK KI;KIM, JUN KU |
分类号 |
A61K31/4178;A61K9/24;A61K9/48;A61K31/505 |
主分类号 |
A61K31/4178 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|